Stroke Trial, Recruiting (NCT06483230)

Stroke Trial, Recruiting NCT06483230 Sponsor: Weill Medical College of Cornell University Condition: Stroke

Printed from Voxsanity (voxsanity.com.au) — NCT06483230 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Stroke

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You must be 18 years of age or older
You must be able to speak and understand English
You must have had a stroke (either a blockage-type or bleeding-type stroke) at least 6 months before joining the study
You must have a moderate level of arm and hand weakness or difficulty following your stroke (confirmed by a specific movement assessment)
You may or may not have difficulty noticing things on one side of your body, which is sometimes called spatial neglect

Who may not be able to join:

You may not be eligible if your arm muscles are significantly stiff or tense (a condition called spasticity), above a certain level as measured by a standard test (confirm with trial site)
You may not be eligible if you are unable to communicate well enough to understand and agree to take part in the study
You may not be eligible if you have serious vision problems
You may not be eligible if you are currently receiving occupational therapy outside of this study
You may not be eligible if you are pregnant or if you are currently incarcerated

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 26 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Joan Stilling, MD,MS, Weill Medical College of Cornell University

Phone: (212) 746-1509

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06483230

Sponsor: Weill Medical College of Cornell University

Phase: Not Applicable

Status: Recruiting

Condition: Stroke

Trial contact: (212) 746-1509

More information: https://clinicaltrials.gov/study/NCT06483230

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You must be 18 years of age or older
You must be able to speak and understand English
You must have had a stroke (either a blockage-type or bleeding-type stroke) at least 6 months before joining the study
You must have a moderate level of arm and hand weakness or difficulty following your stroke (confirmed by a specific movement assessment)
You may or may not have difficulty noticing things on one side of your body, which is sometimes called spatial neglect

Who may not be able to join:

You may not be eligible if your arm muscles are significantly stiff or tense (a condition called spasticity), above a certain level as measured by a standard test (confirm with trial site)
You may not be eligible if you are unable to communicate well enough to understand and agree to take part in the study
You may not be eligible if you have serious vision problems
You may not be eligible if you are currently receiving occupational therapy outside of this study
You may not be eligible if you are pregnant or if you are currently incarcerated

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 26 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Weill Medical College of Cornell University

Registry

ClinicalTrials.gov

Start date

2 October 2024

Est. completion

1 March 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Mean number of sessions attended; Number of serious adverse events

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov